Matt Dellatorre

Stock Analyst at Goldman Sachs

(2.61)
# 2,096
Out of 5,139 analysts
4
Total ratings
100%
Success rate
34.25%
Average return

Stocks Rated by Matt Dellatorre

Teva Pharmaceutical Industries
Dec 19, 2025
Maintains: Buy
Price Target: $31$35
Current: $31.76
Upside: +10.20%
Viatris
Jun 6, 2025
Initiates: Neutral
Price Target: $10
Current: $12.86
Upside: -22.24%